can i get a glp 1 if i'm not overweight You Take Weight Loss Injections You're Overweight? 7 Reasons You Shouldn't Take

When the New Dose Stops Working Sometimes people increase their dose and initially feel strong effects, but after a few weeks the appetite suppression fades again

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)

However, as you get older or if you drink heavily, it's a good idea to keep an eye out for symptoms of low B12

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026 Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models

What conditions are treated with GLP-1 receptor agonists